您的购物车当前为空
别名 卢利珠单抗, BG9588, BG 9588, Anti-Human CD40L Recombinant Antibody
Ruplizumab (BG 9588) 是一种人源化抗 CD40L 的 IgG1κ 类单克隆抗体。Ruplizumab 可用于研究神经系统疾病和免疫系统疾病。

为众多的药物研发团队赋能,
让新药发现更简单!
Ruplizumab (BG 9588) 是一种人源化抗 CD40L 的 IgG1κ 类单克隆抗体。Ruplizumab 可用于研究神经系统疾病和免疫系统疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,980 | In Stock | |
| 5 mg | ¥ 4,980 | In Stock | |
| 10 mg | ¥ 6,880 | In Stock | |
| 25 mg | ¥ 9,870 | In Stock | |
| 50 mg | ¥ 13,700 | In Stock |
Ruplizumab 相关产品
| 产品描述 | Ruplizumab (BG 9588) is a humanized IgG1κ-like monoclonal antibody against CD40L. Ruplizumab is used in the study of neurological and immune system disorders. |
| 别名 | 卢利珠单抗, BG9588, BG 9588, Anti-Human CD40L Recombinant Antibody |
| CAS No. | 220651-94-5 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容